BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 38433845)

  • 1. Serum alpha-fetoprotein response as a preoperative prognostic indicator in unresectable hepatocellular carcinoma with salvage hepatectomy following conversion therapy: a multicenter retrospective study.
    Lin KY; Zhang JX; Lin ZW; Chen QJ; Luo LP; Chen JH; Wang K; Tai S; Zhang ZB; Wang SF; Li JD; Wang K; Zheng L; Zheng SM; Wu MM; Lin KC; Yang T; Zeng YY
    Front Immunol; 2024; 15():1308543. PubMed ID: 38433845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A new prognostic score system of hepatocellular carcinoma following hepatectomy].
    Wang YK; Bi XY; Li ZY; Zhao H; Zhao JJ; Zhou JG; Huang Z; Zhang YF; Li MX; Chen X; Wu XL; Mao R; Hu XH; Hu HJ; Liu JM; Cai JQ
    Zhonghua Zhong Liu Za Zhi; 2017 Dec; 39(12):903-909. PubMed ID: 29262506
    [No Abstract]   [Full Text] [Related]  

  • 3. Perioperative safety, oncologic outcome, and risk factors of salvage liver resection for initially unresectable hepatocellular carcinoma converted by transarterial chemoembolization plus tyrosine kinase inhibitor and anti-PD-1 antibody: a retrospective multicenter study of 83 patients.
    Lin KY; Lin ZW; Chen QJ; Luo LP; Zhang JX; Chen JH; Wang K; Tai S; Zhang ZB; Wang SF; Zhang JY; You WY; Wang B; You PH; Lin KC; Yang T; Zeng YY
    Hepatol Int; 2023 Dec; 17(6):1477-1489. PubMed ID: 37382760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Significance of Preoperative Serum Alpha- fetoprotein in Hepatocellular Carcinoma and Correlation with Clinicopathological Factors: a Single-center Experience from China.
    An SL; Xiao T; Wang LM; Rong WQ; Wu F; Feng L; Liu FQ; Tian F; Wu JX
    Asian Pac J Cancer Prev; 2015; 16(10):4421-7. PubMed ID: 26028108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic implications of alpha-fetoprotein and C-reactive protein elevation in hepatocellular carcinoma following resection (PACE): a large cohort study of 2770 patients.
    Lin KY; Chen QJ; Tang SC; Lin ZW; Zhang JX; Zheng SM; Li YT; Wang XM; Lu Q; Fu J; Guo LB; Zheng LF; You PH; Wu MM; Lin KC; Zhou WP; Yang T; Zeng YY
    BMC Cancer; 2023 Dec; 23(1):1190. PubMed ID: 38053048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic roles of preoperative α-fetoprotein and des-γ-carboxy prothrombin in hepatocellular carcinoma patients.
    Meguro M; Mizuguchi T; Nishidate T; Okita K; Ishii M; Ota S; Ueki T; Akizuki E; Hirata K
    World J Gastroenterol; 2015 Apr; 21(16):4933-45. PubMed ID: 25945007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation analysis of preoperative serum alpha-fetoprotein (AFP) level and prognosis of hepatocellular carcinoma (HCC) after hepatectomy.
    Ma WJ; Wang HY; Teng LS
    World J Surg Oncol; 2013 Aug; 11():212. PubMed ID: 23981851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes of serum alpha-fetoprotein and alpha-fetoprotein-L3 after hepatectomy for hepatocellular carcinoma: prognostic significance.
    Zhang XF; Yin ZF; Wang K; Zhang ZQ; Qian HH; Shi LH
    Hepatobiliary Pancreat Dis Int; 2012 Dec; 11(6):618-23. PubMed ID: 23232633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New nomogram predicts the recurrence of hepatocellular carcinoma in patients with negative preoperative serum AFP subjected to curative resection.
    Gan W; Huang JL; Zhang MX; Fu YP; Yi Y; Jing CY; Fan J; Zhou J; Qiu SJ
    J Surg Oncol; 2018 Jun; 117(7):1540-1547. PubMed ID: 29572833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of combined α-fetoprotein and CA19-9 for hepatocellular carcinoma after hepatectomy.
    Zhang J; Qin SD; Li Y; Lu F; Gong WF; Zhong JH; Ma L; Zhao JF; Zhan GH; Li PZ; Song B; De Xiang B
    World J Surg Oncol; 2022 Oct; 20(1):346. PubMed ID: 36258212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative serum α-fetoprotein and prognosis after hepatectomy for hepatocellular carcinoma.
    Yang SL; Liu LP; Yang S; Liu L; Ren JW; Fang X; Chen GG; Lai PB
    Br J Surg; 2016 May; 103(6):716-724. PubMed ID: 26996727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The α-RECIST (RECIST 1.1 Combined With Alpha Fetoprotein): A Novel Tool for Identifying Tumor Response of Conversion-Radiotherapy for Unresectable Hepatocellular Carcinoma Before Hepatectomy.
    Xu Y; Yang Y; Li L; Ye F; Zhao X
    Front Oncol; 2022; 12():905260. PubMed ID: 35686094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postoperative α-fetoprotein response predicts tumor recurrence and survival after hepatectomy for hepatocellular carcinoma: A propensity score matching analysis.
    Li XL; Zhu XD; Cai H; Li Y; Zhou J; Fan J; Tang ZY; Sun HC
    Surgery; 2019 Jun; 165(6):1161-1167. PubMed ID: 30846192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of nomograms to predict recurrence after conversion hepatectomy for hepatocellular carcinoma previously treated with transarterial interventional therapy.
    Deng M; Zhao R; Guan R; Li S; Zuo Z; Lin W; Wei W; Guo R
    Eur J Med Res; 2023 Sep; 28(1):328. PubMed ID: 37689775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High preoparative levels of serum periostin are associated with poor prognosis in patients with hepatocellular carcinoma after hepatectomy.
    Lv Y; Wang W; Jia WD; Sun QK; Huang M; Zhou HC; Xia HH; Liu WB; Chen H; Sun SN; Xu GL
    Eur J Surg Oncol; 2013 Oct; 39(10):1129-35. PubMed ID: 23916473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Liver Transplantation and Liver Resection for Hepatocellular Carcinoma Patients with Portal Vein Tumor Thrombus Type I and Type II.
    Lv JY; Zhang NN; Du YW; Wu Y; Song TQ; Zhang YM; Qu Y; Liu YX; Gu J; Wang ZY; Qiu YB; Yang B; Tian DZ; Guo QJ; Zhang L; Sun JS; Xie Y; Wang ZL; Sun X; Jiang WT; Lu W
    Yonsei Med J; 2021 Jan; 62(1):29-40. PubMed ID: 33381932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Daily decrease of post-operative alpha-fetoprotein by 9% discriminates prognosis of HCC: A multicenter retrospective study.
    Zhou PY; Yang CP; Tang Z; Yi Y; Liu WR; Tian MX; Huang JL; Gan W; Jiang XF; Liu G; Wang H; Tao CY; Fang Y; Qu WF; Zhou C; Guan RY; Sun BY; Zhou YF; Song SS; Ding ZB; Peng YF; Dai Z; Zhou J; Fan J; Gong GZ; Shi YH; Qiu SJ
    Aging (Albany NY); 2019 Dec; 11(23):11111-11123. PubMed ID: 31829979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum alpha-fetoprotein level per tumor volume reflects prognosis in patients with hepatocellular carcinoma after curative hepatectomy.
    Furihata T; Sawada T; Kita J; Iso Y; Kato M; Rokkaku K; Shimoda M; Kubota K
    Hepatogastroenterology; 2008; 55(86-87):1705-9. PubMed ID: 19102374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Significance of Alpha-Fetoprotein in Alpha-Fetoprotein Negative Hepatocellular Carcinoma Underwent Curative Resection.
    Lin K; Huang Q; Zeng J; Ding Z; Wang L; Chen Z; Guo P; Zeng Y; Zhou W; Liu J
    Dig Dis Sci; 2021 Dec; 66(12):4545-4556. PubMed ID: 33723698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of alpha-fetoprotein and des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma undergoing hepatectomy.
    Yamamoto K; Imamura H; Matsuyama Y; Hasegawa K; Beck Y; Sugawara Y; Makuuchi M; Kokudo N
    Ann Surg Oncol; 2009 Oct; 16(10):2795-804. PubMed ID: 19669841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.